Comparison Chart Thiogenesis Therapeutics, Corp.

Stocks

TTI

CA88410L1022

Biotechnology & Medical Research

Market Closed - Toronto S.E. Other stock markets 15:43:47 2026-07-16 EDT			5-day change	1st Jan Change
0.5300 ^CAD	0.00%		-7.02%	-18.46%

07-13	Thiogenesis Therapeutics Receives Fda Rare Pediatric Disease Designation for Tti-0102 for the Treatment of Leigh Syndrome	CI
07-13	Thiogenesis Therapeutics' Treatment For Leigh Syndrome Receives FDA Rare Pediatric Disease Designation	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	THIOGENESIS THERAPEUTICS, CORP.	Other Biotechnology & Medical Research	0.00%	-7.02%	-18.46%	-33.75%	-	19.57M	-	-	-